Brief: FMR LLC's Long Position In Ordinary Shares Of Zai Lab Rises To 9.26% - HKEX Filing
Jan 27 (Reuters) - Hong Kong stock exchange filing:
* FMR LLC BOUGHT 3.57 MLN ORDINARY SHARES OF ZAI LAB
9688.HK AT
AVG PRICE OF HK$35.485 ($4.53) PER SHARE ON JAN 19 - HKEX
FILING
* FMR LLC'S LONG POSITION IN ORDINARY SHARES OF ZAI LAB
RISES TO
9.26% ON JAN 19 FROM 8.90% - HKEX FILING
Source text
Further company coverage: 9688.HK
($1 = 7.8290 Hong Kong dollars)
(Reporting by Hong Kong newsroom)
((twinnie.siu@tr.com; 852-3462 7715;))
Recent news on Zai Lab
See all newsBrief: Zai Lab Says ZL-1503 Was Well Tolerated With No Serious Adverse Events
Brief: Zai Lab Agrees To Issue To Investors Aggregate Of 11.3 Million ADSs
Zai Lab's Hong Kong shares hit three-month high on quarterly revenue beat
Brief: U.S. FDA Grants Orphan Drug Designation To Zai Lab’S Dll3-Targeting Adc Zocilurtatug Pelitecan (Zoci) For The Treatment Of Neuroendocrine Carcinomas (Necs)
Brief: Goldman Sachs Group's Long Position In Zai Lab Decreases On May 14, HKEX Filing Shows